Emory University has announced a $50 million commitment from the Atlanta-based Goizueta Foundation to establish the Goizueta Institute @Emory Brain Health.

According to the university, research indicates that many neurological and psychiatric diseases share an early stage that begins long before symptoms appear, suggesting opportunities for disease prediction and prevention. With collaborative teams across multiple areas including neurology, psychiatry, primary care, and sleep medicine, the Goizueta Institute @Emory Brain Health will work to advance research that informs clinical care by standardizing assessments of brain function across brain diseases with shared symptoms and genetic causes; develop a data technology platform for integrating clinical and research data that enables advanced analytics; establish a repository for biospecimens to fuel development and application of next generation biomarkers; and identify and diagnose brain disease at the earliest stage possible, optimize treatment, and ultimately prevent disease.

With the most recent gift, the foundation has committed more than $100 million in support of Emory Brain Health since 2014.

“This generous grant will combine Emory’s strengths in clinical and discovery neuroscience to fuel the Goizueta Institute @Emory Brain Health’s trailblazing efforts to develop a new, data-driven approach to medicine,” said Jonathan S. Lewin, executive vice president for health affairs and Emory Healthcare CEO. “It will advance our understanding across the spectrum of brain health and ultimately transform the way we prevent and treat brain disease in order to improve lives and provide hope.”